Building an Internal Centre of Excellence for Digital Health Policy and Strategy In an era where digital health is rapidly evolving, establishing an internal Centre of Excellence (CoE) focused on digital health policy and strategy is vital for organizations looking to navigate the complex regulatory landscape. This guide provides a detailed, step-by-step approach to building such a CoE, especially in alignment with the FDA’s digital health frameworks, pre-certification pilot programs, and emerging policies. Leaders in digital health, regulatory affairs, clinical research, and quality assurance should understand these concepts to successfully deploy Software as a Medical Device (SaMD), mobile applications, and…

Scenario Planning Around Potential Future AI and SaMD Rulemaking As digital health technologies evolve, the regulatory landscape surrounding Software as a Medical Device (SaMD) and Artificial Intelligence (AI) solutions is similarly transforming. This article serves as a comprehensive guide for digital health, regulatory, clinical, and quality leaders tasked with navigating future AI and SaMD regulatory frameworks. We will explore the potential scenarios regarding the FDA’s pre-certification pilot and emerging policies, equipping professionals with the insights necessary for proactive decision-making. Understanding the Current Regulatory Landscape for Digital Health Before delving into scenario planning, it is crucial to grasp the existing regulatory…

Preparing internal stakeholders for upcoming digital health regulatory changes Preparing Internal Stakeholders for Upcoming Digital Health Regulatory Changes The landscape of digital health is rapidly evolving, and with it, the regulatory framework established by agencies like the U.S. Food and Drug Administration (FDA). Understanding the implications of the FDA digital health pre-certification (Pre-Cert) pilot program and emerging policies is critical for internal stakeholders in digital health ecosystems. This article serves as a comprehensive, step-by-step tutorial aimed at equipping digital health, regulatory, clinical, and quality leaders with the necessary knowledge and tools to navigate these changes effectively. Understanding FDA Digital Health…

Governance for Responding to New FDA Digital Health Expectations and Guidances The digital health landscape is continuously evolving, influenced by rapid technological advancements and emerging regulatory frameworks. With the introduction of innovative pathways and regulatory sandboxes, organizations working with Software as a Medical Device (SaMD), mobile applications, and artificial intelligence (AI) solutions must align their governance structures with new FDA expectations. This guide provides a comprehensive, step-by-step tutorial for digital health, regulatory, clinical, and quality leaders on how to navigate these changes effectively. Understanding FDA Digital Health Policies The FDA has made significant strides in developing a regulatory framework tailored…

Using Regulatory Intelligence Tools to Monitor Emerging Digital Policies The rapid evolution of digital health technologies, particularly Software as a Medical Device (SaMD), apps, and artificial intelligence (AI) solutions, necessitates a proactive approach to regulatory compliance. For regulatory professionals, staying ahead of emerging policies from the US Food and Drug Administration (FDA), as well as counterparts in the UK and EU, is imperative. This comprehensive guide outlines a step-by-step approach to leveraging regulatory intelligence tools effectively for monitoring evolving regulatory landscapes. Understanding the Landscape of FDA Digital Health Regulations As digital health solutions gain traction in clinical practice, regulatory frameworks…